Effects of the Bifidobacterium Longum BL21 on BMI, Metabolic Indicators, and Gut Microbiota in Overweight/Obese Adults | MicrobiomeTrials← Back to trialsNCT06140641
Effects of the Bifidobacterium Longum BL21 on BMI, Metabolic Indicators, and Gut Microbiota in Overweight/Obese Adults
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-11-29Est. Completion: 2024-07-30
Enrollment target: 72 participants Locations- Qilu hospital, Jinnan, Shandong, China
Other microbiome trials you might be interested in
Obesity
A 12-month randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 6-month weight loss perio…
Chicago, United StatesCompleted Feb 1, 2025
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)OverweightMetabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026
Phase 4
Recruiting
This study investigates the Topical-Lingual (T-L) delivery of semaglutide, a GLP-1 receptor agonist (GLP-1RA), via an or…
Minneapolis, United StatesEst. completion May 2027